allergan limited
allergan limited Company Information
Company Number
01049760
Next Accounts
Sep 2025
Shareholders
allergan holdings ltd
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
ground floor marlow internationa, parkway, marlow, SL7 1YL
Website
www.allergan.co.ukallergan limited Estimated Valuation
Pomanda estimates the enterprise value of ALLERGAN LIMITED at £0 based on a Turnover of £0 and 0.39x industry multiple (adjusted for size and gross margin).
allergan limited Estimated Valuation
Pomanda estimates the enterprise value of ALLERGAN LIMITED at £0 based on an EBITDA of £0 and a 3.96x industry multiple (adjusted for size and gross margin).
allergan limited Estimated Valuation
Pomanda estimates the enterprise value of ALLERGAN LIMITED at £420m based on Net Assets of £219.1m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Allergan Limited Overview
Allergan Limited is a live company located in marlow, SL7 1YL with a Companies House number of 01049760. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 1972, it's largest shareholder is allergan holdings ltd with a 100% stake. Allergan Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Allergan Limited Health Check
Pomanda's financial health check has awarded Allergan Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 3 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
3 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Allergan Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (5.3%)
- - Allergan Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Allergan Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Allergan Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (36)
- Allergan Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Allergan Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Allergan Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Allergan Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Allergan Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Allergan Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (11 weeks)
- - Allergan Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.3%, this is a lower level of debt than the average (54.7%)
- - Allergan Limited
- - Industry AVG
ALLERGAN LIMITED financials
Allergan Limited's latest turnover from December 2023 is 0 and the company has net assets of £219.1 million. According to their latest financial statements, we estimate that Allergan Limited has 1 employee and maintains cash reserves of £13 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 45,944,000 | 187,109,000 | 182,983,000 | 220,741,000 | 195,522,000 | 215,128,000 | 206,406,000 | 166,183,000 | 119,880,000 | 117,983,000 | 110,508,000 | 101,466,000 | 91,963,000 | 80,140,000 | |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 28,387,000 | 94,753,000 | 78,894,000 | 109,828,000 | 110,556,000 | 125,187,000 | 114,418,000 | 88,420,000 | 84,505,000 | 86,813,000 | 83,954,000 | 70,974,000 | 66,711,000 | 54,659,000 | |
| Gross Profit | 17,557,000 | 92,356,000 | 104,089,000 | 110,913,000 | 84,966,000 | 89,941,000 | 91,988,000 | 77,763,000 | 35,375,000 | 31,170,000 | 26,554,000 | 30,492,000 | 25,252,000 | 25,481,000 | |
| Admin Expenses | 17,920,000 | 85,441,000 | 96,948,000 | 102,144,000 | 75,896,000 | 78,362,000 | 84,078,000 | 65,706,000 | 18,240,000 | 23,853,000 | 15,269,000 | 22,092,000 | 19,173,000 | 20,050,000 | |
| Operating Profit | -363,000 | 6,915,000 | 7,141,000 | 8,769,000 | 9,070,000 | 11,579,000 | 7,910,000 | 12,057,000 | 17,135,000 | 7,317,000 | 11,285,000 | 8,400,000 | 6,079,000 | 5,431,000 | |
| Interest Payable | 96,000 | 428,000 | 605,000 | 589,000 | 90,000 | 115,000 | 113,000 | 108,000 | 145,000 | 121,000 | 6,000 | 138,000 | 2,132,000 | 227,000 | |
| Interest Receivable | 10,280,000 | 2,693,000 | 102,000 | 146,000 | 7,000 | 16,000 | 38,000 | 95,000 | 96,000 | 1,689,000 | 39,000 | ||||
| Pre-Tax Profit | 10,280,000 | 146,715,000 | 6,487,000 | 6,638,000 | 8,326,000 | 8,980,000 | 11,464,000 | 7,797,000 | 11,956,000 | 17,006,000 | 7,183,000 | 11,163,000 | 8,206,000 | 5,636,000 | 5,002,000 |
| Tax | -2,418,000 | -108,000 | -3,542,000 | 285,000 | -2,354,000 | -435,000 | -4,266,000 | 643,000 | -62,000 | -439,000 | -594,000 | -2,053,000 | -895,000 | -99,000 | -154,000 |
| Profit After Tax | 7,862,000 | 146,607,000 | 2,945,000 | 6,923,000 | 5,972,000 | 8,545,000 | 7,198,000 | 8,440,000 | 11,894,000 | 16,567,000 | 6,589,000 | 9,110,000 | 7,311,000 | 5,537,000 | 4,848,000 |
| Dividends Paid | 5,000,000 | 6,000,000 | 6,000,000 | 15,000,000 | 2,000,000 | ||||||||||
| Retained Profit | 7,862,000 | 146,607,000 | 2,945,000 | 6,923,000 | 5,972,000 | 8,545,000 | 7,198,000 | 8,440,000 | 6,894,000 | 10,567,000 | 589,000 | -5,890,000 | 7,311,000 | 5,537,000 | 2,848,000 |
| Employee Costs | 8,030,000 | 32,652,000 | 33,378,000 | 31,420,000 | 27,071,000 | 28,758,000 | 28,310,000 | 27,286,000 | 34,083,000 | 32,408,000 | 42,501,000 | 43,621,000 | 35,733,000 | 34,103,000 | |
| Number Of Employees | 68 | 288 | 285 | 283 | 279 | 283 | 281 | 254 | 336 | 349 | 453 | 444 | 386 | 356 | |
| EBITDA* | -13,000 | 8,382,000 | 8,881,000 | 12,527,000 | 11,038,000 | 12,570,000 | 8,753,000 | 12,862,000 | 18,249,000 | 8,524,000 | 11,994,000 | 9,371,000 | 6,817,000 | 6,253,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 11,699,000 | 14,374,000 | 17,296,000 | 4,461,000 | 5,993,000 | 6,303,000 | 6,787,000 | 7,001,000 | 9,525,000 | 10,584,000 | 7,178,000 | 6,006,000 | 6,647,000 | ||
| Intangible Assets | 1,586,000 | 4,162,000 | 1,586,000 | 1,586,000 | 1,586,000 | 1,586,000 | 1,586,000 | 1,586,000 | 1,031,000 | 1,110,000 | 1,190,000 | 1,269,000 | 1,348,000 | ||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 13,285,000 | 18,536,000 | 18,882,000 | 6,047,000 | 7,579,000 | 7,889,000 | 8,373,000 | 8,587,000 | 10,556,000 | 11,694,000 | 8,368,000 | 7,275,000 | 7,995,000 | ||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 23,987,000 | 25,942,000 | 33,376,000 | 26,357,000 | 27,732,000 | 30,774,000 | 18,059,000 | 17,553,000 | 18,530,000 | 15,713,000 | 15,687,000 | 14,791,000 | 13,738,000 | ||
| Group Debtors | 220,650,000 | 209,421,000 | 86,988,000 | 24,548,000 | 37,616,000 | 26,172,000 | 55,398,000 | 36,027,000 | 46,347,000 | 74,620,000 | 23,711,000 | 26,742,000 | 42,170,000 | 42,252,000 | 35,050,000 |
| Misc Debtors | 1,225,000 | 842,000 | 3,043,000 | 3,522,000 | 1,552,000 | 1,881,000 | 3,824,000 | 2,180,000 | 2,224,000 | 2,513,000 | 2,043,000 | 2,335,000 | 4,225,000 | 3,820,000 | 3,134,000 |
| Cash | 13,000 | 963,000 | 15,613,000 | 54,327,000 | 36,010,000 | 37,867,000 | 3,595,000 | 3,342,000 | 241,000 | 856,000 | 105,000 | 1,346,000 | 1,840,000 | 2,049,000 | |
| misc current assets | |||||||||||||||
| total current assets | 221,888,000 | 211,226,000 | 129,631,000 | 108,339,000 | 108,554,000 | 92,277,000 | 90,549,000 | 72,323,000 | 66,871,000 | 94,686,000 | 45,140,000 | 44,895,000 | 63,428,000 | 62,703,000 | 53,971,000 |
| total assets | 221,888,000 | 211,226,000 | 142,916,000 | 126,875,000 | 127,436,000 | 98,324,000 | 98,128,000 | 80,212,000 | 75,244,000 | 103,273,000 | 55,696,000 | 56,589,000 | 71,796,000 | 69,978,000 | 61,966,000 |
| Bank overdraft | 215,000 | ||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 3,614,000 | 2,922,000 | 5,384,000 | 2,479,000 | 3,095,000 | 2,541,000 | 1,477,000 | 1,166,000 | 4,319,000 | 2,634,000 | 2,130,000 | 276,000 | 623,000 | ||
| Group/Directors Accounts | 2,800,000 | 38,411,000 | 24,469,000 | 30,668,000 | 22,671,000 | 29,104,000 | 47,860,000 | 13,463,000 | 16,210,000 | 16,094,000 | 14,819,000 | 12,336,000 | |||
| other short term finances | |||||||||||||||
| hp & lease commitments | 4,340,000 | 4,060,000 | 4,054,000 | ||||||||||||
| other current liabilities | 16,450,000 | 17,095,000 | 45,849,000 | 47,363,000 | 24,073,000 | 23,177,000 | 20,059,000 | 26,635,000 | 12,615,000 | 12,868,000 | 15,373,000 | 18,419,000 | 16,093,000 | ||
| total current liabilities | 2,800,000 | 62,815,000 | 48,546,000 | 55,287,000 | 49,842,000 | 57,836,000 | 48,389,000 | 50,640,000 | 75,876,000 | 30,397,000 | 31,712,000 | 33,597,000 | 33,514,000 | 29,052,000 | |
| loans | 31,980,000 | ||||||||||||||
| hp & lease commitments | 9,629,000 | 12,764,000 | 15,990,000 | ||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 5,482,000 | 5,258,000 | 8,632,000 | 7,702,000 | 4,913,000 | 4,660,000 | 6,544,000 | 10,009,000 | 3,877,000 | 2,861,000 | 2,417,000 | 835,000 | 3,796,000 | ||
| total long term liabilities | 15,111,000 | 18,022,000 | 20,306,000 | 3,851,000 | 4,913,000 | 4,660,000 | 6,544,000 | 10,009,000 | 5,064,000 | 4,154,000 | 6,769,000 | 6,911,000 | 9,117,000 | ||
| total liabilities | 2,800,000 | 77,926,000 | 66,568,000 | 75,593,000 | 53,693,000 | 62,749,000 | 53,049,000 | 57,184,000 | 85,885,000 | 35,461,000 | 35,866,000 | 40,366,000 | 40,425,000 | 38,169,000 | |
| net assets | 219,088,000 | 211,226,000 | 64,990,000 | 60,307,000 | 51,843,000 | 44,631,000 | 35,379,000 | 27,163,000 | 18,060,000 | 17,388,000 | 20,235,000 | 20,723,000 | 31,430,000 | 29,553,000 | 23,797,000 |
| total shareholders funds | 219,088,000 | 211,226,000 | 64,990,000 | 60,307,000 | 51,843,000 | 44,631,000 | 35,379,000 | 27,163,000 | 18,060,000 | 17,388,000 | 20,235,000 | 20,723,000 | 31,430,000 | 29,553,000 | 23,797,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -363,000 | 6,915,000 | 7,141,000 | 8,769,000 | 9,070,000 | 11,579,000 | 7,910,000 | 12,057,000 | 17,135,000 | 7,317,000 | 11,285,000 | 8,400,000 | 6,079,000 | 5,431,000 | |
| Depreciation | 350,000 | 1,467,000 | 1,516,000 | 3,758,000 | 1,968,000 | 991,000 | 843,000 | 805,000 | 1,035,000 | 1,128,000 | 629,000 | 892,000 | 659,000 | 743,000 | |
| Amortisation | 224,000 | 79,000 | 79,000 | 80,000 | 79,000 | 79,000 | 79,000 | ||||||||
| Tax | -2,418,000 | -108,000 | -3,542,000 | 285,000 | -2,354,000 | -435,000 | -4,266,000 | 643,000 | -62,000 | -439,000 | -594,000 | -2,053,000 | -895,000 | -99,000 | -154,000 |
| Stock | |||||||||||||||
| Debtors | 11,612,000 | 96,245,000 | 60,006,000 | -18,532,000 | 18,134,000 | -32,544,000 | 17,973,000 | 2,351,000 | -28,056,000 | 50,402,000 | -506,000 | -17,292,000 | 1,219,000 | 8,941,000 | 51,922,000 |
| Creditors | -3,614,000 | 692,000 | -2,462,000 | 2,905,000 | -616,000 | 554,000 | 1,064,000 | 311,000 | -3,153,000 | 1,685,000 | 504,000 | 1,854,000 | -347,000 | 623,000 | |
| Accruals and Deferred Income | -16,450,000 | -645,000 | -28,754,000 | -1,514,000 | 23,290,000 | 896,000 | 3,118,000 | -6,576,000 | 14,020,000 | -253,000 | -2,505,000 | -3,046,000 | 2,326,000 | 16,093,000 | |
| Deferred Taxes & Provisions | -5,482,000 | 224,000 | -3,374,000 | 930,000 | 2,789,000 | 253,000 | -1,884,000 | -3,465,000 | 6,132,000 | 1,016,000 | 444,000 | 1,582,000 | -2,961,000 | 3,796,000 | |
| Cash flow from operations | -14,030,000 | -121,912,000 | -54,895,000 | -6,892,000 | -5,640,000 | -7,966,000 | 9,343,000 | 31,126,000 | -15,593,000 | 10,884,000 | 25,676,000 | 7,647,000 | -3,205,000 | -25,311,000 | |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 2,800,000 | -38,411,000 | 13,942,000 | 24,469,000 | -30,668,000 | 7,997,000 | -6,433,000 | -18,756,000 | 34,397,000 | -2,747,000 | 116,000 | 1,275,000 | 2,483,000 | 12,336,000 | |
| Other Short Term Loans | |||||||||||||||
| Long term loans | -31,980,000 | 31,980,000 | |||||||||||||
| Hire Purchase and Lease Commitments | -13,969,000 | -2,855,000 | -3,220,000 | 20,044,000 | |||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 10,280,000 | 2,597,000 | -428,000 | -503,000 | -443,000 | -90,000 | -115,000 | -113,000 | -101,000 | -129,000 | -83,000 | 89,000 | -42,000 | -443,000 | -188,000 |
| cash flow from financing | 13,080,000 | -50,154,000 | 12,397,000 | -9,693,000 | 52,821,000 | -30,051,000 | 8,900,000 | -5,883,000 | -25,079,000 | 20,854,000 | -3,907,000 | -4,612,000 | -4,201,000 | 2,259,000 | 33,097,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -950,000 | -14,650,000 | -38,714,000 | 18,317,000 | -1,857,000 | 34,272,000 | 253,000 | 3,101,000 | 241,000 | -856,000 | 751,000 | -1,241,000 | -494,000 | -209,000 | 2,049,000 |
| overdraft | -215,000 | 215,000 | |||||||||||||
| change in cash | -950,000 | -14,650,000 | -38,714,000 | 18,317,000 | -1,857,000 | 34,272,000 | 253,000 | 3,101,000 | 456,000 | -1,071,000 | 751,000 | -1,241,000 | -494,000 | -209,000 | 2,049,000 |
allergan limited Credit Report and Business Information
Allergan Limited Competitor Analysis
Perform a competitor analysis for allergan limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mature companies, companies in SL7 area or any other competitors across 12 key performance metrics.
allergan limited Ownership
ALLERGAN LIMITED group structure
Allergan Limited has 1 subsidiary company.
Ultimate parent company
ABBVIE INC
#0082475
2 parents
ALLERGAN LIMITED
01049760
1 subsidiary
allergan limited directors
Allergan Limited currently has 3 directors. The longest serving directors include Mr Paul Johnson (Aug 2018) and Mr Aaron Sibley (Feb 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Johnson | England | 52 years | Aug 2018 | - | Director |
| Mr Aaron Sibley | England | 47 years | Feb 2019 | - | Director |
| Mr Nicholas Hudson | England | 49 years | Feb 2019 | - | Director |
P&L
December 2023turnover
0
-100%
operating profit
0
-100%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
219.1m
+0.04%
total assets
221.9m
+0.05%
cash
13k
-0.99%
net assets
Total assets minus all liabilities
Similar Companies
allergan limited company details
company number
01049760
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
April 1972
age
53
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
ERNST & YOUNG LLP
address
ground floor marlow internationa, parkway, marlow, SL7 1YL
Bank
-
Legal Advisor
-
allergan limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to allergan limited. Currently there are 0 open charges and 2 have been satisfied in the past.
allergan limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ALLERGAN LIMITED. This can take several minutes, an email will notify you when this has completed.
allergan limited Companies House Filings - See Documents
| date | description | view/download |
|---|
